Moffitt Cancer Center announces executive leadership for new campus

Moffitt Cancer Center recently announced the leader of its Pasco campus, Speros. Josh Carpenter, who holds a doctorate in philosophy, will serve as the president of Speros and Moffitt’s chief integration officer.

“Carpenter brings a rare blend of visionary leadership and economic expertise that will propel Speros into its next phase of growth,” says Dr. Patrick Hwu, president and CEO of Moffitt, in a statement. “With his guidance, we will shape Speros into a global model for groundbreaking discoveries and patient outcomes.”

Courtesy image

According to Moffitt, Carpenter will unite Speros and Moffitt’s clinical and research expertise with commercial partners to accelerate breakthroughs in cancer prevention and treatment. He will also serve as the chief integration officer and vice president for Moffitt, overseeing alignment between the cancer center and Speros. 

Carpenter’s background is in translational research, biotech commercialization and economic development. Most recently he was president and CEO of Southern Research, a nonprofit research institute dedicated to drug discovery, genomic data science and biotechnology. 

Under his leadership, the institute secured over $100 million in capital to upgrade lab space and focus on biotech initiatives, including the creation of a clinical-genomic database, according to the statement. He also spearheaded efforts that awarded $44 million in federal funding to establish Birmingham as a designated regional tech hub.

In another role, his work included launching the Birmingham Promise, which raised $24 million to fund apprenticeships and scholarships for public school students. 

Moffitt Cancer Center opened in 1986 and had $2 billion in revenue in 2023, according to ProPublica. The hospital announced the 775-acre Speros campus plan in 2022. As of now, it is slated for a January 2026 opening.